查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032597

核醫放射性同位素市場：按產品、應用、最終用戶和地區分類（2026-2034 年）

Nuclear Medicine Radioisotopes Market by Product, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球核醫放射性同位素市場規模達84億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以6.99%的複合年成長率成長，到2034年達到157億美元。癌症發病率上升、對核醫學藥物的需求不斷成長以及各種技術的進步是推動市場成長的主要因素。

核子醫學放射性同位素是用於診斷和治療各種疾病的放射性物質。這些放射性同位素會發射輻射，透過偵測和測量輻射，可以獲得有關體內器官和組織結構及功能的資訊。它們主要用於診斷和治療。在診斷應用中，放射性同位素用於產生體內器官和系統的圖像。這使得醫務人員能夠識別異常情況並診斷癌症、心臟病和神經系統疾病等病症。在治療應用中，放射性同位素用於針對癌細胞和體內其他異常組織的標靶放射治療。此外，與傳統的診斷和治療方法相比，核醫放射性同位素具有許多優勢。它們屬於非侵入性治療，無需手術切口或其他侵入性操作，與化療和放射線治療等治療方法相比，副作用和併發症的風險更低。由於這些優勢，核醫放射性同位素在世界各地的醫院中已廣泛應用。

核醫放射性同位素市場趨勢：

癌症患者數量的不斷成長是推動該市場成長的主要因素。核醫放射性同位素廣泛應用於癌症診斷（例如PET掃描）和治療領域。此外，老年人口的不斷成長，以及他們容易罹患癌症、心臟病和神經系統疾病等慢性病，也是推動市場成長的另一個主要因素，因為這需要使用核醫放射性同位素。同時，各種技術的進步正在推動核醫學放射性同位素在診斷和治療方面的新型和改進應用的發展。這些因素，加上對核子醫學投資和需求的不斷成長，正在積極影響市場成長。政府和私人機構正在大力投資核醫技術的研究和開發，從而催生新產品和新應用，最終推動市場成長。此外，患者對輻射和放射療法的認知不斷提高也促進了市場成長。醫療保健成本的上升、先進產品的推出以及主要公司研發活動的活性化，也是改善市場前景的因素。

本報告解答的主要問題

  • 全球核醫放射性同位素市場迄今的發展軌跡如何？預計未來幾年將如何發展？
  • 全球核醫用放射性同位素市場的主要促進因素、阻礙因素和機會是什麼？
  • 各種促進因素​​、阻礙因素和機會如何影響核醫放射性同位素的全球市場？
  • 主要區域市場有哪些？
  • 哪個國家對核醫放射性同位素的需求量最大？
  • 以產品來看，市場區隔是如何計算的？
  • 在核醫學用放射性同位素市場中，哪種產品最具吸引力？
  • 按應用領域分類的市場區隔如何？
  • 核子醫學放射性同位素市場中最具吸引力的應用有哪些？
  • 依最終用戶分類的市場區隔如何？
  • 在核醫放射性同位素市場中，哪個終端用戶最具吸引力？
  • 全球核醫放射性同位素市場的競爭格局如何？
  • 全球核醫放射性同位素市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：核醫放射性同位素的全球市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 診斷
    • 主要部分
      • Technetium-99m (Tc-99m)
      • 鎵-67
      • 鉈-201
      • 氟-18
      • 其他
  • 治療
    • 主要部分
      • 錸-186
      • 碘-131
      • 釤-153
      • 釔-90
      • 其他

第7章 市場區隔：依應用領域分類

  • 循環系統
  • 腫瘤學
  • 甲狀腺
  • 神經病學
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷中心
  • 專科診所
  • 教育和研究機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Bracco SpA
    • Bruce Power Inc.
    • Cardinal Health Inc.
    • China Isotope & Radiation Corporation（China National Nuclear Corporation）
    • Curium Pharma
    • Eckert & Ziegler
    • Nordion（Canada）Inc（Sotera Health Company）
    • NorthStar Medical Radioisotopes, LLC
    • NTP Radioisotopes SOC Ltd
    • Shine Technologies LLC
Product Code: SR112026A7532

The global nuclear medicine radioisotopes market size reached USD 8.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.99% during 2026-2034. The rising prevalence of cancer, the escalating demand for nuclear medicines, and various technological advancements represent some of the key factors driving the market.

Nuclear medicine radioisotopes are radioactive substances that are used in diagnostic and therapeutic procedures for various medical conditions. These radioisotopes emit radiation, which can be detected and measured to provide information about the structure and function of organs and tissues in the body. They are mainly utilized for diagnostic and therapeutic applications. In diagnostic applications, radioisotopes are employed to create images of the body's internal organs and systems. This allows healthcare professionals to identify abnormalities and diagnose conditions such as cancer, heart disease, and neurological disorders. On the other hand, in therapeutic applications, radioisotopes are used to deliver targeted radiation therapy to cancer cells or other abnormal tissues in the body. Moreover, nuclear medicine radioisotopes have several advantages over traditional diagnostic and therapeutic procedures as they are non-invasive, do not require surgical incisions or other invasive procedures, and have a lower risk of side effects and complications compared to treatments such as chemotherapy or radiation therapy. Owing to these benefits, nuclear medicine radioisotopes are widely utilized in hospitals across the globe.

NUCLEAR MEDICINE RADIOISOTOPES MARKET TRENDS:

The market is primarily driven by the growing prevalence of cancer among individuals. Nuclear medicine radioisotopes are widely used in cancer diagnosis solutions such as PET scans and treatment therapies. In addition, the rising geriatric population that is more susceptible to chronic diseases such as cancer, heart disease, and neurological disorders, which require the use of nuclear medicine radioisotopes, represents another major growth-inducing factor. Besides this, various technological advancements have led to the development of new and improved diagnostic and therapeutic applications of nuclear medicine radioisotopes. This, coupled with the increasing investment and demand for nuclear medicines, is positively influencing market growth. Governments and private organizations are investing heavily in the research and development of nuclear medicine technologies, leading to the creation of new products and applications, which in turn is driving the market growth. Moreover, the market is also propelled by the growing patient awareness about radiation and radiation therapy. Furthermore, the rising healthcare expenditure, the launch of advanced product variants, and increasing research and development activities conducted by key players are other factors creating a favorable market outlook.

KEY MARKET SEGMENTATION:

Product Insights:

  • Diagnostics
    • Technetium-99m (Tc-99m)
    • Gallium-67
    • Thallium-201
    • Fluorine-18
    • Others
  • Therapeutics
    • Rhenium-186
    • Iodine-131
    • Samarium-153
    • Yttrium-90
    • Others

Application Insights:

  • Cardiology
  • Oncology
  • Thyroid
  • Neurology

End User Insights:

  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics
  • Education and Research Institutes

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for nuclear medicine radioisotopes. Some of the factors driving the North America nuclear medicine radioisotopes market included aging population, technological advancements, rising prevalence of cancer.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global nuclear medicine radioisotopes market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bracco S.p.A., Bruce Power Inc., Cardinal Health Inc., China Isotope & Radiation Corporation (China National Nuclear Corporation), Curium Pharma, Eckert & Ziegler, Nordion (Canada) Inc (Sotera Health Company), NorthStar Medical Radioisotopes, LLC, NTP Radioisotopes SOC Ltd.,Shine Technologies LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global nuclear medicine radioisotopes market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine radioisotopes market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine radioisotopes market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the nuclear medicine radioisotopes market?
  • What is the competitive structure of the global nuclear medicine radioisotopes market?
  • Who are the key players/companies in the global nuclear medicine radioisotopes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Radioisotopes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Technetium-99m (Tc-99m)
      • 6.1.2.2 Gallium-67
      • 6.1.2.3 Thallium-201
      • 6.1.2.4 Fluorine-18
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Rhenium-186
      • 6.2.2.2 Iodine-131
      • 6.2.2.3 Samarium-153
      • 6.2.2.4 Yttrium-90
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Cardiology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Thyroid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neurology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Education and Research Institutes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bracco S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Bruce Power Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Cardinal Health Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 China Isotope & Radiation Corporation (China National Nuclear Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Curium Pharma
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Eckert & Ziegler
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Nordion (Canada) Inc (Sotera Health Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 NorthStar Medical Radioisotopes, LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 NTP Radioisotopes SOC Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Shine Technologies LLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nuclear Medicine Radioisotopes Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Radioisotopes Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Nuclear Medicine Radioisotopes Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Nuclear Medicine Radioisotopes Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Nuclear Medicine Radioisotopes Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Nuclear Medicine Radioisotopes Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Nuclear Medicine Radioisotopes (Cardiology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Nuclear Medicine Radioisotopes (Cardiology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Nuclear Medicine Radioisotopes (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Nuclear Medicine Radioisotopes (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Nuclear Medicine Radioisotopes (Thyroid) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Nuclear Medicine Radioisotopes (Thyroid) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Nuclear Medicine Radioisotopes (Neurology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Nuclear Medicine Radioisotopes (Neurology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Nuclear Medicine Radioisotopes (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Nuclear Medicine Radioisotopes (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Nuclear Medicine Radioisotopes (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Nuclear Medicine Radioisotopes (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Nuclear Medicine Radioisotopes (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Nuclear Medicine Radioisotopes (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Nuclear Medicine Radioisotopes Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Nuclear Medicine Radioisotopes Industry: Value Chain Analysis
  • Figure 83: Global: Nuclear Medicine Radioisotopes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Radioisotopes Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Nuclear Medicine Radioisotopes Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Radioisotopes Market: Key Players